Literature DB >> 24658002

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.

Leora Witkowski1, Jian Carrot-Zhang2, Steffen Albrecht3, Somayyeh Fahiminiya4, Nancy Hamel5, Eva Tomiak6, David Grynspan7, Emmanouil Saloustros8, Javad Nadaf4, Barbara Rivera9, Catherine Gilpin6, Ester Castellsagué9, Rachel Silva-Smith10, François Plourde10, Mona Wu9, Avi Saskin11, Madeleine Arseneault4, Rouzan G Karabakhtsian12, Elizabeth A Reilly13, Frederick R Ueland13, Anna Margiolaki8, Kitty Pavlakis14, Sharon M Castellino15, Janez Lamovec16, Helen J Mackay17, Lawrence M Roth18, Thomas M Ulbright18, Tracey A Bender18, Vassilis Georgoulias8, Michel Longy19, Andrew Berchuck20, Marc Tischkowitz21, Inga Nagel22, Reiner Siebert22, Colin J R Stewart23, Jocelyne Arseneau24, W Glenn McCluggage25, Blaise A Clarke26, Yasser Riazalhosseini4, Martin Hasselblatt27, Jacek Majewski4, William D Foulkes28.   

Abstract

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age. We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 of 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24658002     DOI: 10.1038/ng.2931

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  50 in total

Review 1.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

2.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Authors:  Miriam J Smith; Andrew J Wallace; Naomi L Bowers; Cecilie F Rustad; C Geoff Woods; Guy D Leschziner; Rosalie E Ferner; D Gareth R Evans
Journal:  Neurogenetics       Date:  2012-03-22       Impact factor: 2.660

3.  Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.

Authors:  Felix Distelmaier; Gabriele Calaminus; Dieter Harms; Ronald Sträter; Uwe Kordes; Gudrun Fleischhack; Ulrich Göbel; Dominik T Schneider
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

Review 4.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

5.  Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: a calcitonin-responsive line derived from a rare tumor type.

Authors:  K S Upchurch; L M Parker; R E Scully; S M Krane
Journal:  J Bone Miner Res       Date:  1986-06       Impact factor: 6.741

6.  An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type.

Authors:  W G McCluggage; E Oliva; L E Connolly; H A McBride; R H Young
Journal:  Int J Gynecol Pathol       Date:  2004-10       Impact factor: 2.762

7.  Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.

Authors:  Boris G Wilson; Katherine C Helming; Xiaofeng Wang; Youngha Kim; Francisca Vazquez; Zainab Jagani; William C Hahn; Charles W M Roberts
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

8.  Primary ovarian small cell carcinoma: four more cases.

Authors:  F Peccatori; C Bonazzi; V Lucchini; G Bratina; C Mangioni
Journal:  Gynecol Oncol       Date:  1993-04       Impact factor: 5.482

9.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

10.  Classification of human ovarian tumors.

Authors:  R E Scully
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

View more
  137 in total

Review 1.  Biology and Treatment of Rhabdoid Tumor.

Authors:  James I Geller; Jacquelyn J Roth; Jaclyn A Biegel
Journal:  Crit Rev Oncog       Date:  2015

2.  SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Authors:  Thomas G Papathomas; Lindsey Oudijk; Alexandre Persu; Anthony J Gill; Francien van Nederveen; Arthur S Tischler; Frédérique Tissier; Marco Volante; Xavier Matias-Guiu; Marcel Smid; Judith Favier; Elena Rapizzi; Rosella Libe; Maria Currás-Freixes; Selda Aydin; Thanh Huynh; Urs Lichtenauer; Anouk van Berkel; Letizia Canu; Rita Domingues; Roderick J Clifton-Bligh; Magdalena Bialas; Miikka Vikkula; Gustavo Baretton; Mauro Papotti; Gabriella Nesi; Cécile Badoual; Karel Pacak; Graeme Eisenhofer; Henri J Timmers; Felix Beuschlein; Jérôme Bertherat; Massimo Mannelli; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo; Winand Nm Dinjens; Esther Korpershoek; Ronald R de Krijger
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

3.  PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.

Authors:  Thomas Januario; Xiaofen Ye; Russell Bainer; Bruno Alicke; Tunde Smith; Benjamin Haley; Zora Modrusan; Stephen Gould; Robert L Yauch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

Review 4.  Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Authors:  Till Holsten; Susanne Bens; Florian Oyen; Karolina Nemes; Martin Hasselblatt; Uwe Kordes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim; Ulrich Schüller
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

5.  Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.

Authors:  Rajmohan Murali; Pier Selenica; David N Brown; R Keira Cheetham; Raghu Chandramohan; Nidia L Claros; Nancy Bouvier; Donavan T Cheng; Robert A Soslow; Britta Weigelt; W Glenn McCluggage
Journal:  Histopathology       Date:  2019-01-15       Impact factor: 5.087

Review 6.  Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.

Authors:  Roodolph St Pierre; Cigall Kadoch
Journal:  Curr Opin Genet Dev       Date:  2017-04-06       Impact factor: 5.578

Review 7.  SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications.

Authors:  Takeshi Fukumoto; Elizabeth Magno; Rugang Zhang
Journal:  Mol Cancer Res       Date:  2018-07-23       Impact factor: 5.852

8.  Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.

Authors:  Luiz H Araujo; Cynthia Timmers; Erica Hlavin Bell; Konstantin Shilo; Philip E Lammers; Weiqiang Zhao; Thanemozhi G Natarajan; Clinton J Miller; Jianying Zhang; Ayse S Yilmaz; Tom Liu; Kevin Coombes; Joseph Amann; David P Carbone
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 9.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

10.  Ovarian small cell carcinoma in one of a pair of monozygous twins.

Authors:  Somayyeh Fahiminiya; Nelly Sabbaghian; Steffen Albrecht; Javad Nadaf; Donato Callegaro-Filho; William D Foulkes
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.